Related Experiment Video
Updated: Jul 13, 2026
Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
Published on: August 9, 2024
Surgical management of spasticity of cerebral origin in children
1Department of Neurosurgery, Birmingham Children's Hospital, Birmingham, UK. S.Sgouros@bham.ac.uk
Insights
Managing spasticity in children with cerebral palsy (CP) involves tailored treatments. Intrathecal baclofen (ITB) is a key surgical option, with technology improving patient-friendly pumps.
Area of Science:
- Pediatric Neurology
- Neurosurgery
- Rehabilitation Medicine
Background:
- Spasticity in children often relates to cerebral palsy (CP), brain injury, or other insults.
- CP involves physical impairment of movement due to abnormal brain development.
- Management strategies for pediatric spasticity are individualized based on clinical presentation.
Purpose of the Study:
- To review the current management of spasticity in children.
- To highlight the role of intrathecal baclofen (ITB) as a primary surgical treatment.
- To discuss the trend towards reversible infusion systems over ablative treatments.
Main Methods:
- Review of clinical management approaches for pediatric spasticity.
- Focus on surgical interventions like dorsal rhizotomy and ITB.
- Discussion of patient selection criteria for different treatments.
Main Results:
- Ambulatory children with mild spastic diplegia may benefit from dorsal rhizotomy or ITB.
- Non-ambulatory patients with severe spasticity often receive ITB as a first-line surgical treatment.
- There is a shift from ablative procedures to reversible ITB systems.
Conclusions:
- Intrathecal baclofen (ITB) is a leading surgical option for managing severe pediatric spasticity.
- Technological advancements are expected to improve the patient-friendliness of ITB pumps.
- Individualized treatment plans are crucial for optimizing outcomes in children with spasticity.
Abstract:
In children, spasticity is commonly seen in the context of cerebral palsy (CP), but also following head injury, cerebral infarct or other brain insults. CP is a wide term used to describe a constellation of symptoms that characterise the physical impairment of movement due to abnormal brain development. The management of spasticity is tailored according to the clinical picture of the child. Ambulatory mild spastic diplegics tend to reach the maximum of their disability in the first few years of life, and change little after the age of 5-7 years. Such patients who are between 3-5 years and who attempt to mobilise with walking frames are often good candidates for either dorsal rhizotomy or intrathecal baclofen (ITB) administration with the implantation of an indwelling pump. Non-ambulatory mild spastic diplegics and spastic quadriplegics have more profound spasticity, painful spasms, orthopaedic deformities, and difficulties with daily care and posture. ITB has become established as the first line of surgical treatment for these patients. In the last decade, there has been a definite trend away from ablative treatments and towards reversible stimulation and infusion systems. Current pumps have practical limitations but, in the next decade, it is anticipated that technological improvements will render the pumps more patient friendly.
Related Concept Videos
01:31Skeletal Muscle Relaxants: Therapeutic Uses
01:29Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...